The Kleihauer test is a simple blood test on the mother that looks for and counts the baby's red blood cells that have passed into her circulation (foetomaternal haemorrhage). It is mainly used, in a rhesus-negative woman, to adjust the dose of anti-D immunoglobulin after bleeding, a blow to the abdomen, a procedure or birth. It also helps to understand certain situations, such as anaemia in the baby or reduced baby movements.
During pregnancy, a small amount of the baby’s blood can pass into the mother’s circulation: this is called foetomaternal haemorrhage. It is usually tiny and harmless. It becomes important in two situations:
The Kleihauer test estimates the amount of foetal blood that has passed to the mother. It is one of the tests carried out in maternity units, particularly in the emergency department and on the labour ward when you are giving birth in Paris.
The baby’s red blood cells mainly contain foetal haemoglobin, whereas adult red blood cells contain adult haemoglobin. In the laboratory, a smear of the mother’s blood is placed in an acid solution:
The laboratory scientist counts the foetal red blood cells under the microscope, usually per 10,000 maternal red blood cells. The volume of foetal blood that has passed to the mother is then estimated by calculation.
The test is simple and inexpensive, but reading it by hand is imprecise. Some laboratories use flow cytometry, a more reproducible automated technique based on the same principle of detecting foetal haemoglobin.
In France, the Kleihauer test is mainly useful from the second trimester, when the baby’s blood volume is large enough for a significant transfer to be possible.
| Situation | Why the test? |
|---|---|
| Bleeding in the second or third trimester | Adjust the anti-D dose in a rhesus-negative woman; assess a large transfer of blood |
| Blow or injury to the abdomen (fall, car accident) | Look for transfer of foetal blood, even without visible bleeding |
| Amniocentesis, external cephalic version, late cervical stitch | Adjust anti-D prevention if needed |
| Birth in a rhesus-negative woman with a rhesus-positive baby | Check that the standard anti-D dose is enough |
| Reduced baby movements, abnormal foetal heart rate, foetal anaemia suspected on ultrasound | Look for a large foetomaternal haemorrhage as the cause |
| Stillbirth (intrauterine foetal death) | Part of the investigations to find a cause |
Before 12 weeks of pregnancy (weeks of amenorrhoea), after a miscarriage, a missed miscarriage, an abortion or bleeding in an ongoing pregnancy, the French College of Gynaecologists and Obstetricians (CNGOF) has recommended since 2024 that anti-D immunoglobulin should not be given (weak recommendation, very low-quality evidence); the Kleihauer test is of no use at this stage. For an ectopic pregnancy, the CNGOF makes no recommendation (insufficient evidence): your team will decide case by case. Some teams still give it routinely, in line with the 2021 French National Authority for Health (HAS) factsheet on medical abortion; your doctor will explain the approach used. For bleeding in early pregnancy, see our article on bleeding in the first trimester.
The test carries no risk for you or your baby. It can be repeated if a new event occurs later in pregnancy, for example a second episode of bleeding. Each at-risk situation is assessed separately, because the protection given by an anti-D injection fades over time and sometimes needs to be repeated. Your pregnancy record keeps track of injections and results.
The report gives the number of foetal red blood cells per 10,000 maternal red blood cells, and sometimes the estimated volume of foetal blood transferred.
The test has limits. Some women produce a little foetal haemoglobin themselves, particularly with thalassaemia, sickle cell disease or sometimes during pregnancy: the test may then overestimate the transfer. Conversely, if the mother’s and baby’s ABO blood groups are incompatible, foetal red blood cells may be destroyed quickly and the test may underestimate the transfer. The team therefore always interprets the result in the light of the clinical situation.
If you are rhesus negative, your care includes several steps, set out in the CNGOF guidelines:
According to the American College of Obstetricians and Gynecologists (ACOG), giving anti-D after birth reduced the risk of alloimmunisation from about 13 to 16% to 0.5 to 1.8%, and adding an injection during pregnancy lowered it to 0.14 to 0.2%.
Go to the maternity emergency department or, if symptoms are severe, in France call 15 (SAMU) or 112, or your local emergency number, if you have:
If you are rhesus negative, say so as soon as you arrive and bring your blood group card. The 72-hour window for an anti-D injection after an at-risk event is one of the reasons not to delay seeking care. See also our article on bleeding in the second and third trimesters.
Would you like a medical opinion?Appointments in Paris 16th or 5th, or by video consultation.
Book an appointmentYes, in some cases. It is not then used for anti-D prevention, but it can look for a large transfer of foetal blood when baby movements are reduced, foetal anaemia is suspected or after a stillbirth.
No. It is an ordinary blood test with no special preparation.
No. The baby's rhesus group is determined by a different test, foetal rhesus genotyping on the mother's blood, or by testing the newborn's blood group at birth.
When the transfer of foetal blood is large, the team may check that prevention has worked, for example by measuring the injected anti-D antibodies, to decide whether an extra dose is needed.
A question about your situation?Appointments at the practice or by video consultation, usually within one week to 10 days.
Book an appointmentGeneral information article: it does not replace a medical consultation. In an emergency, call 15 or 112 in France, or your local emergency number.